Search results for "Supervivència"

showing 6 items of 6 documents

Impact of BCR-ABL1 Transcript Type on Response, Treatment-Free Remission Rate and Survival in Chronic Myeloid Leukemia Patients Treated with Imatinib

2021

Chronic myeloid leukemia; BCR-ABL1 transcripts; Response to imatinib Leucemia mieloide crónica; Transcripciones de BCR-ABL1; Respuesta al imatinib Leucèmia mieloide crònica; Transcripcions BCR-ABL1; Resposta a imatinib The most frequent BCR-ABL1-p210 transcripts in chronic myeloid leukemia (CML) are e14a2 and e13a2. Imatinib (IM) is the most common first-line tyrosine–kinase inhibitor (TKI) used to treat CML. Some studies suggest that BCR-ABL1 transcript types confer different responses to IM. The objective of this study was to correlate the expression of e14a2 or e13a2 to clinical characteristics, cumulative cytogenetic and molecular responses to IM, acquisition of deep molecular response …

Oncologymedicine.medical_specialtyrelapse-free survivalLeucèmia mieloide<i>BCR</i><i>-ABL1</i> transcriptsLeucèmia mieloide crònica:Organic Chemicals::Amides::Benzamides::Imatinib Mesylate [CHEMICALS AND DRUGS]survivalArticleOncología:Neoplasms::Neoplasms by Histologic Type::Leukemia::Leukemia Myeloid::Leukemia Myelogenous Chronic BCR-ABL Positive [DISEASES]03 medical and health sciencesBcr abl10302 clinical medicineAnàlisi de supervivència (Biometria)chronic myeloid leukemiaInternal medicinehemic and lymphatic diseasesresponse to imatinibmedicineOverall survivalHematologíaCumulative incidenceBCR-ABL1 transcriptsGene transcriptbusiness.industryRMyeloid leukemiaImatinibGeneral MedicineExpressió gènica:técnicas de investigación::métodos epidemiológicos::estadística como asunto::análisis de supervivencia [TÉCNICAS Y EQUIPOS ANALÍTICOS DIAGNÓSTICOS Y TERAPÉUTICOS]Myeloid leukemia030220 oncology & carcinogenesisMolecular ResponseImatinib:compuestos orgánicos::amidas::benzamidas::mesilato de imatinib [COMPUESTOS QUÍMICOS Y DROGAS]MedicineRemission rateGene expression:Health Care Quality Access and Evaluation::Quality of Health Care::Health Care Evaluation Mechanisms::Statistics as Topic::Survival Analysis [HEALTH CARE]business:neoplasias::neoplasias por tipo histológico::leucemia::leucemia mieloide::leucemia mielogenosa crónica BCR-ABL positiva [ENFERMEDADES]030215 immunologymedicine.drugdiscontinuation
researchProduct

Survival trends for primary liver cancer, 1995–2009: analysis of individual data for 578,740 patients from 187 population-based registries in 36 coun…

2019

CONCORD Working Group Members: Africa—Algeria: S Bouzbid (Registre du Cancer d’Annaba); M Hamdi-Chérif*, Z Zaidi (Registre du Cancer de Sétif); Gambia: R Swaminathan (National Cancer Registry); Lesotho: SH Nortje (Children’s Haematology Oncology Clinics - Lesotho); Libya: MM El Mistiri (Benghazi Cancer Registry); Mali: S Bayo, B Malle (Kankou Moussa University); Mauritius: SS Manraj, R Sewpaul-Sungkur (Mauritius National Cancer Registry); Nigeria: A Fabowale, OJ Ogunbiyi* (Ibadan Cancer Registry); South Africa: D Bradshaw, NIM Somdyala (Eastern Cape Province Cancer Registry); DC Stefan (Umtata University); Tunisia: L Jaidane, M Mokni (Registre du Cancer du Centre Tunisien).
America (Central…

trendsFunnel plotmedicine.medical_specialtySurvivalPopulationPsychological interventionSocio-culturaleIntrahepatic bile ductsSettore MED/42 - Igiene Generale E Applicataliver cancerhepatocellular carcinoma (HCC)SDG 3 - Good Health and Well-beingInternal medicinemedicinecancer registryeducationSupervivènciaeducation.field_of_studybusiness.industryFetge -- Càncer -- EstadístiquesCancerGeneral MedicineLiver -- Cancer -- Statisticsmedicine.diseasetrendInvasive Malignant NeoplasmHepatocellular carcinomainternational/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_beingLiver cancerbusinesscholangiocarcinomaSurvival trends liver cancer hepatocellular carcinoma (HCC) cholangiocarcinoma cancer registry international
researchProduct

Frequentist and Bayesian approaches for a joint model for prostate cancer risk and longitudinal prostate-specific antigen data

2015

The paper describes the use of frequentist and Bayesian shared-parameter joint models of longitudinal measurements of prostate-specific antigen (PSA) and the risk of prostate cancer (PCa). The motivating dataset corresponds to the screening arm of the Spanish branch of the European Randomized Screening for Prostate Cancer study. The results show that PSA is highly associated with the risk of being diagnosed with PCa and that there is an age-varying effect of PSA on PCa risk. Both the frequentist and Bayesian paradigms produced very close parameter estimates and subsequent 95% confidence and credibility intervals. Dynamic estimations of disease-free probabilities obtained using Bayesian infe…

Statistics and ProbabilityPREDICTIONBayesian probabilityurologic and male genital diseasesBayesian inferenceGeneralized linear mixed modelPSAProstate cancerLATENT CLASS MODELSAnàlisi de supervivència (Biometria)Frequentist inference62N01Statisticsprostate cancer screeningSurvival analysis (Biometry)FAILUREMedicineProstate cancer riskTO-EVENT DATAbusiness.industryjoint modelsMORTALITYDISEASE PROGRESSIONmedicine.diseaselinear mixed modelsTIMEProstate-specific antigenProstate cancer screeningshared-parameter models:Matemàtiques i estadística::Estadística matemàtica [Àrees temàtiques de la UPC]62P10SURVIVALStatistics Probability and Uncertaintyrelative risk modelsFOLLOW-UPbusinessJournal of Applied Statistics
researchProduct

Short implants (8mm) versus longer implants (≥8mm) with lateral sinus floor augmentation in posterior atrophic maxilla: A meta-analysis of RCT`s in h…

2019

Background One of the greatest challenges that dentists face today is to rehabilitate severe atrophied alveolar ridges in partially and completely edentulous patients with implants. Despite the high survival rate of implants placed next to sinus elevation, this technique presents complications that can be avoided by placing short implants, an option that also presents high survival rates. For this reason, the aim of this study is to compare the survival rate, marginal bone loss and complications associated with short implants (<8 mm) versus longer implants (≥8mm) placed with lateral sinus floor elevation in posterior atrophic maxillae. Material and Methods A literature search was conducted …

Survival rateComplicationsAugment del sòl sinusal lateralDentistryReviewlaw.invention0302 clinical medicineRandomized controlled triallawMaxillaMedicineDental Restoration FailurePèrdua òssia marginalImplante cortoImplantes dentalesDental Implantation Endosseous:CIENCIAS MÉDICAS [UNESCO]Lateral sinusShort implantsTreatment OutcomeRandomized controlled trialMeta-analysisUNESCO::CIENCIAS MÉDICASLateral sinus floor augmentationOdontologyImplantologySinus Floor AugmentationPérdida ósea marginalEnsayo controlado aleatorizadoSinus Floor AugmentationOdontología616.3Odontologia03 medical and health sciencesAumento del suelo del seno lateralStatistical significanceTasa de supervivenciaHumansAssaig controlat aleatoriGeneral DentistrySurvival rateDental ImplantsImplants dentalsComplicacionsbusiness.industryMarginal bone lossTaxa de supervivènciaImplant curt030206 dentistryComplicacionesShort implantOtorhinolaryngologyDental Prosthesis DesignMaxillaSurgerybusinessMedicina oral, patologia oral y cirugia bucal
researchProduct

Global surveillance of cancer survival 1995–2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 coun…

2015

Worldwide data for cancer survival are scarce. We aimed to initiate worldwide surveillance of cancer survival by central analysis of population-based registry data, as a metric of the eff ectiveness of health systems, and to inform global policy on cancer control. Methods Individual tumour records were submitted by 279 population-based cancer registries in 67 countries for 25·7 million adults (age 15–99 years) and 75 000 children (age 0–14 years) diagnosed with cancer during 1995–2009 and followed up to Dec 31, 2009, or later. We looked at cancers of the stomach, colon, rectum, liver, lung, breast (women), cervix, ovary, and prostate in adults, and adult and childhood leukaemia. Standardise…

Maleeurope 1999-2007PathologyCàncer -- EstadístiquesSurvival[SDV]Life Sciences [q-bio]2700 General MedicineGlobal HealthSettore MED/42 - Igiene Generale E ApplicataNeoplasms80 and overGlobal healthRegistriesStomach cancerChildcancer survivalBreast-cancerComputingMilieux_MISCELLANEOUScancer registry; cancer survival; worldwideCervical cancerAged 80 and overeducation.field_of_studychildhood-cancerMedicine (all)1. No povertyGeneral Medicinecancer survival; population-based registries; surveillanceMiddle Aged3. Good healthovarian-cancerChild Preschoolpopulation-based registriesurveillance/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_beingFemalenet survivalNeoplasms/mortalityBreast-cancer; childhood-cancer; rectal-cancer; nordic countries; europe 1999-2007; ovarian-cancer; net survival; data quality; care; stageAdultmedicine.medical_specialtyAdolescentPopulationSocio-culturale610 Medicine & healthAdolescent; Adult; Age Distribution; Aged; Aged 80 and over; Child; Child Preschool; Female; Global Health; Humans; Infant; Infant Newborn; Male; Middle Aged; Neoplasms; Registries; Sex Distribution; Survival Analysis; Young Adult; Medicine (all)Articlerectal-cancerYoung AdultBreast cancerAge DistributionSDG 3 - Good Health and Well-beingcancer survival; cancer registriesmedicinedata qualityHumanscareSex DistributionPreschooleducationSupervivèncianordic countriesSurvival analysisddc:613AgedCancer -- Statisticsbusiness.industryInfant NewbornCancerInfant10060 Epidemiology Biostatistics and Prevention Institute (EBPI)Newbornmedicine.diseasestageSurvival AnalysisCancer registrycancer registriesbusinessDemography
researchProduct

Síntomas, signos y estadística: Aplicaciones de la estadística en ciencias de la salud y de la vida

2014

La determinación o constatación experimental de los mecanismos fisiológicos de las enfermedades suele ser una tarea muy compleja. Esto ha convertido a la epidemiología en la principal herramienta de generación de conocimiento en el ámbito médico. La epidemiología aprende sobre las enfermedades a partir de la observación de la salud en colectivos de personas, en lugar de la observación individual de éstas. Si la principal herramienta de generación de conocimiento médico se basa en la observación de colectivos de personas (muestras de una población) de las que querremos aprender (hacer inferencia), resulta claro el nexo entre la estadística y la medicina. A lo largo de este artículo ilustramo…

clinical trialssupervivenciabioestadística; ciencias de la salud y de la vida; ensayos clínicos; epidemiología; supervivenciastatistics; computer scienceciències de la salut i de la vidabiostatisticscomputer scienceciencias de la salud y de la vidasurvivalbiostatistics; health and life sciences; clinical trials; epidemiology; survivalestadísticaestadística; medicinabioestadísticastatisticsensayos clínicosassajos clínicsbioestadística; ciències de la salut i de la vida; assajos clínics; epidemiologia; supervivènciahealth and life sciencesepidemiologyepidemiologiasupervivènciamedicinaepidemiología
researchProduct